The Grünenthal Group is an entrepreneurial, science-based pharmaceutical company specialized in pain, gout and inflammation. Our ambition is to deliver new products to patients in diseases with high unmet medical need.
Grünenthal is a fully integrated research & development company with a long track record of bringing innovative pain treatments and state-of-the-art technologies to patients. By sustainably investing in R&D above the industrial average, Grünenthal is strongly committed to innovation.
Grünenthal is an independent, family-owned company headquartered in Aachen, Germany. Grünenthal is present in 32 countries with affiliates in Europe, Latin America and the US. It´s products are sold in more than 155 countries and approx. 5,500 employees are working for the Grünenthal Group worldwide.